{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:07:26Z","timestamp":1790060846957,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To examine whether access to treatment for women with opioid use disorder (OUD) varied by race and ethnicity, community characteristics, and pregnancy status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We conducted a secondary data analysis of a simulated patient caller study of buprenorphine-waivered prescribers and opioid-treatment programs in 10 U.S. states. We conducted multivariable analyses, accounting for potential confounders, to evaluate factors associated with likelihood of successfully securing an appointment. Descriptive statistics and significance testing examined 1) caller characteristics and call outcome by assigned race and ethnicity and clinic type (combined, opioid-treatment programs, and buprenorphine-waivered prescribers) and 2) clinic and community characteristics and call outcome by community race and ethnicity distribution (majority White vs majority Black, Hispanic, Asian, American Indian, Alaska Native, Native Hawaiian, or Pacific Islander) and clinic type. A multiple logistic regression model was fitted to assess the likelihood of obtaining an appointment by callers' race and ethnicity and pregnancy status with the exposure of interest being majority Black, Hispanic, Asian, American Indian, Alaska Native, Native Hawaiian, or Pacific Islander community distribution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>In total, 3,547 calls reached clinics to schedule appointments. Buprenorphine-waivered prescribers were more likely to be in communities that were more than 50% White (88.9% vs 77.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001), and opioid-treatment programs were more likely to be in communities that were less than 50% White (11.1% vs 22.7%, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;.001). Callers were more likely to be granted appointments in majority Black, Hispanic, Asian, American Indian, Alaska Native, Native Hawaiian, or Pacific Islander communities (adjusted odds ratio [aOR] 1.06, 95% CI 1.02\u20131.10 per 10% Black, Hispanic, Asian, American Indian, Alaska Native, Native Hawaiian, or Pacific Islander community population) and at opioid-treatment programs (aOR 4.94, 95% CI 3.52\u20136.92) and if they were not pregnant (aOR 1.79, 95% CI 1.53\u20132.09).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Clinic distribution and likelihood of acceptance for treatment varied by community race and ethnicity distribution. Access to treatment for OUD remains challenging for pregnant people and in many historically marginalized U.S. communities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005227","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T21:03:08Z","timestamp":1689886988000},"page":"339-349","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Patient and Community Factors Affecting Treatment Access for Opioid Use Disorder"],"prefix":"10.1097","volume":"142","author":[{"given":"Dominique","family":"Bulgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamarra","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"McNeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velma McBride","family":"Murry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0000000000001446","article-title":"Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic","volume":"128","author":"Krans","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1360-0443.2011.03700.x","article-title":"Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings","volume":"107","author":"Schwartz","year":"2012","journal-title":"Addiction"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1542\/peds.58.5.681","article-title":"Differential effects of maternal heroin and methadone use on birthweight","volume":"58","author":"Kandall","year":"1976","journal-title":"Pediatrics"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2105\/AJPH.2012.301049","article-title":"Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009","volume":"103","author":"Schwartz","year":"2013","journal-title":"Am J Public Health"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11524-010-9451-7","article-title":"Impact of interim methadone maintenance on HIV risk behaviors","volume":"87","author":"Wilson","year":"2010","journal-title":"J Urban Health"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jsat.2011.01.008","article-title":"Interim methadone treatment compared to standard methadone treatment: 4-month findings","volume":"41","author":"Schwartz","year":"2011","journal-title":"J Substance Abuse Treat"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"103786","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int J Drug Policy"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"108927","DOI":"10.1016\/j.drugalcdep.2021.108927","article-title":"Racial inequity in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use","volume":"227","author":"Hollander","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2105\/AJPH.2020.306031","article-title":"Evolving intersectionality within public health: from analysis to action","volume":"111","author":"Bowleg","year":"2021","journal-title":"Am J Public Health"},{"key":"R13-20250423","first-page":"139","article-title":"Demarginalizing the intersection of race and sex: a Black feminist critique of antidiscrimination doctrine, feminist theory and antiracist politics","volume":"1989","author":"Crenshaw","year":"2015","journal-title":"Univ Chicago Leg Forum"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1377\/hlthaff.2011.0983","article-title":"Blacks and Hispanics are less likely than Whites to complete addiction treatment, largely due to socioeconomic factors","volume":"32","author":"Saloner","year":"2013","journal-title":"Health Aff"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"e2029043","DOI":"10.1001\/jamanetworkopen.2020.29043","article-title":"Prevalence and geographic distribution of obstetrician-gynecologists who treat Medicaid enrollees and are trained to prescribe buprenorphine","volume":"3","author":"Nguemeni Tiako","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/10826084.2021.1949611","article-title":"Social stigma toward persons with opioid use disorder: results from a nationally representative survey of U.S. adults","volume":"56","author":"Taylor","year":"2021","journal-title":"Subst Use Misuse"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"e2013456","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees","volume":"39","author":"Stein","year":"2018","journal-title":"Subst Abuse"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"e227028","DOI":"10.1001\/jamanetworkopen.2022.7028","article-title":"Assessment of community-level vulnerability and access to medications for opioid use disorder","volume":"5","author":"Joudrey","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible: the Neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"107615","DOI":"10.1016\/j.drugalcdep.2019.107615","article-title":"Religious involvement and racial disparities in opioid use disorder between 2004\u20132005 and 2012\u20132013: results from the national epidemiologic survey on alcohol and related conditions","volume":"205","author":"Ransome","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1377\/hlthaff.2021.00460","article-title":"Neonatal opioid withdrawal syndrome is associated with infant foster care entry at the county level","volume":"40","author":"Loch","year":"2021","journal-title":"Health Aff"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J Addict Med"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1017\/S089803061600035X","article-title":"Treating addiction or reducing crime? Methadone maintenance and drug policy under the Nixon administration","volume":"29","author":"Raz","year":"2017","journal-title":"J Policy Hist"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","article-title":"Addressing racial and ethnic disparities in the use of medications for opioid use disorder","volume":"40","author":"Andraka-Christou","year":"2021","journal-title":"Health Aff"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"108146","DOI":"10.1016\/j.jsat.2020.108146","article-title":"A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder","volume":"119","author":"Cioe","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qual Health Res"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","article-title":"Is the prescription opioid epidemic a White problem?","volume":"106","author":"Hansen","year":"2016","journal-title":"Am J Public Health"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T20:00:16Z","timestamp":1745438416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005227","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"2022-11-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}